<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Havre PA</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>CD26/dipeptidyl peptidase IV (DPPIV) is a multifunctional membrane protein with a key role in T-cell biology and also serves as a marker of aggressive cancers, including T-cell malignancies.&lt;h4>Methods&lt;/h4>Versican expression was measured by real-time RT-PCR and Western blots. Gene silencing of versican in parental Karpas 299 cells was performed using transduction-ready viral particles. The effect of versican depletion on surface expression of MT1-MMP was monitored by flow cytometry and surface biotinylation. CD44 secretion/cleavage and ERK (1/2) activation was followed by Western blotting. Collagenase I activity was measured by a live cell assay and in vesicles using a liquid-phase assay. Adhesion to collagen I was quantified by an MTS assay.&lt;h4>Results&lt;/h4>Versican exp</pubmed_abstract><journal>BMC cancer</journal><pagination>517</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4228418</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>CD26 expression on T-anaplastic large cell lymphoma (ALCL) line Karpas 299 is associated with increased expression of versican and MT1-MMP and enhanced adhesion.</pubmed_title><pmcid>PMC4228418</pmcid><pubmed_authors>Havre PA</pubmed_authors><pubmed_authors>Ohnuma K</pubmed_authors><pubmed_authors>Morimoto C</pubmed_authors><pubmed_authors>Iwata S</pubmed_authors><pubmed_authors>Dang LH</pubmed_authors><pubmed_authors>Dang NH</pubmed_authors></additional><is_claimable>false</is_claimable><name>CD26 expression on T-anaplastic large cell lymphoma (ALCL) line Karpas 299 is associated with increased expression of versican and MT1-MMP and enhanced adhesion.</name><description>&lt;h4>Background&lt;/h4>CD26/dipeptidyl peptidase IV (DPPIV) is a multifunctional membrane protein with a key role in T-cell biology and also serves as a marker of aggressive cancers, including T-cell malignancies.&lt;h4>Methods&lt;/h4>Versican expression was measured by real-time RT-PCR and Western blots. Gene silencing of versican in parental Karpas 299 cells was performed using transduction-ready viral particles. The effect of versican depletion on surface expression of MT1-MMP was monitored by flow cytometry and surface biotinylation. CD44 secretion/cleavage and ERK (1/2) activation was followed by Western blotting. Collagenase I activity was measured by a live cell assay and in vesicles using a liquid-phase assay. Adhesion to collagen I was quantified by an MTS assay.&lt;h4>Results&lt;/h4>Versican exp</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Nov</publication><modification>2025-04-22T18:40:22.773Z</modification><creation>2021-02-21T06:04:24Z</creation></dates><accession>S-EPMC4228418</accession><cross_references><pubmed>24180670</pubmed><doi>10.1186/1471-2407-13-517</doi></cross_references></HashMap>